BCAL Diagnostics Ltd
BDX
Company Profile
Business description
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.
Contact
Queen Victoria Building
GPO Box Q128
SydneyNSW1230
AUSSector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,765.70 | 5.40 | -0.06% |
| CAC 40 | 7,683.73 | 58.51 | -0.76% |
| DAX 40 | 23,434.65 | 264.47 | -1.12% |
| Dow JONES (US) | 42,215.80 | 299.29 | -0.70% |
| FTSE 100 | 8,834.03 | 41.19 | -0.46% |
| HKSE | 23,698.65 | 281.65 | -1.17% |
| NASDAQ | 19,521.09 | 180.12 | -0.91% |
| Nikkei 225 | 38,795.11 | 258.37 | 0.67% |
| NZX 50 Index | 12,619.33 | 20.02 | -0.16% |
| S&P 500 | 5,982.72 | 50.39 | -0.84% |
| S&P/ASX 200 | 8,538.60 | 2.70 | -0.03% |
| SSE Composite Index | 3,380.47 | 6.94 | -0.20% |